These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33785922)

  • 1. DPP9 restrains NLRP1 activation.
    Bauernfried S; Hornung V
    Nat Struct Mol Biol; 2021 Apr; 28(4):333-336. PubMed ID: 33785922
    [No Abstract]   [Full Text] [Related]  

  • 2. DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation.
    Griswold AR; Ball DP; Bhattacharjee A; Chui AJ; Rao SD; Taabazuing CY; Bachovchin DA
    ACS Chem Biol; 2019 Nov; 14(11):2424-2429. PubMed ID: 31525884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding.
    Zhong FL; Robinson K; Teo DET; Tan KY; Lim C; Harapas CR; Yu CH; Xie WH; Sobota RM; Au VB; Hopkins R; D'Osualdo A; Reed JC; Connolly JE; Masters SL; Reversade B
    J Biol Chem; 2018 Dec; 293(49):18864-18878. PubMed ID: 30291141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation.
    Hollingsworth LR; Sharif H; Griswold AR; Fontana P; Mintseris J; Dagbay KB; Paulo JA; Gygi SP; Bachovchin DA; Wu H
    Nature; 2021 Apr; 592(7856):778-783. PubMed ID: 33731932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling.
    Harapas CR; Robinson KS; Lay K; Wong J; Moreno Traspas R; Nabavizadeh N; Rass-Rothschild A; Boisson B; Drutman SB; Laohamonthonkul P; Bonner D; Xiong JR; Gorrell MD; Davidson S; Yu CH; Fleming MD; Gudera J; Stein J; Ben-Harosh M; Groopman E; Shimamura A; Tamary H; Kayserili H; Hatipoğlu N; Casanova JL; Bernstein JA; Zhong FL; Masters SL; Reversade B
    Sci Immunol; 2022 Sep; 7(75):eabi4611. PubMed ID: 36112693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic lymphohistiocytosis-like hyperinflammation due to a de novo mutation in DPP9.
    Wolf C; Fischer H; Kühl JS; Koss S; Jamra RA; Starke S; Schultz J; Ehl S; Neumann K; Schuetz C; Huber R; Hornung V; Lee-Kirsch MA
    J Allergy Clin Immunol; 2023 Nov; 152(5):1336-1344.e5. PubMed ID: 37544411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and biochemical mechanisms of NLRP1 inhibition by DPP9.
    Huang M; Zhang X; Toh GA; Gong Q; Wang J; Han Z; Wu B; Zhong F; Chai J
    Nature; 2021 Apr; 592(7856):773-777. PubMed ID: 33731929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages.
    de Vasconcelos NM; Vliegen G; Gonçalves A; De Hert E; Martín-Pérez R; Van Opdenbosch N; Jallapally A; Geiss-Friedlander R; Lambeir AM; Augustyns K; Van Der Veken P; De Meester I; Lamkanfi M
    Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30718379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity.
    Moecking J; Laohamonthonkul P; Chalker K; White MJ; Harapas CR; Yu CH; Davidson S; Hrovat-Schaale K; Hu D; Eng C; Huntsman S; Calleja DJ; Horvat JC; Hansbro PM; O'Donoghue RJJ; Ting JP; Burchard EG; Geyer M; Gerlic M; Masters SL
    J Allergy Clin Immunol; 2021 Jun; 147(6):2134-2145.e20. PubMed ID: 33378691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasome sensor NLRP1 disease variant M1184V promotes autoproteolysis and DPP9 complex formation by stabilizing the FIIND domain.
    Moecking J; Laohamonthonkul P; Meşe K; Hagelueken G; Steiner A; Harapas CR; Sandow JJ; Graves JD; Masters SL; Geyer M
    J Biol Chem; 2022 Dec; 298(12):102645. PubMed ID: 36309085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common variant close to the "tripwire" linker region of NLRP1 contributes to severe COVID-19.
    Leal VNC; Paulino LM; Cambui RAG; Zupelli TG; Yamada SM; Oliveira LAT; Dutra VF; Bub CB; Sakashita AM; Yokoyama APH; Kutner JM; Vieira CA; Santiago WMS; Andrade MMS; Teixeira FME; Alberca RW; Gozzi-Silva SC; Yendo TM; Netto LC; Duarte AJS; Sato MN; Venturini J; Pontillo A
    Inflamm Res; 2023 Nov; 72(10-11):1933-1940. PubMed ID: 36416944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.
    Sharif H; Hollingsworth LR; Griswold AR; Hsiao JC; Wang Q; Bachovchin DA; Wu H
    Immunity; 2021 Jul; 54(7):1392-1404.e10. PubMed ID: 34019797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances toward structure-based drug discovery for inflammasome targets.
    Wang L; Crackower MA; Wu H
    J Exp Med; 2022 Jan; 219(1):. PubMed ID: 34783859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation.
    Orth-He EL; Huang HC; Rao SD; Wang Q; Chen Q; O'Mara CM; Chui AJ; Saoi M; Griswold AR; Bhattacharjee A; Ball DP; Cross JR; Bachovchin DA
    Cell Rep; 2023 Jan; 42(1):111965. PubMed ID: 36649711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the CARD8 Inflammasome Requires a Disordered Region.
    Chui AJ; Griswold AR; Taabazuing CY; Orth EL; Gai K; Rao SD; Ball DP; Hsiao JC; Bachovchin DA
    Cell Rep; 2020 Oct; 33(2):108264. PubMed ID: 33053349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KSHV-encoded ORF45 activates human NLRP1 inflammasome.
    Yang X; Zhou J; Liu C; Qu Y; Wang W; Xiao MZX; Zhu F; Liu Z; Liang Q
    Nat Immunol; 2022 Jun; 23(6):916-926. PubMed ID: 35618833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPP8/9 inhibitors are universal activators of functional NLRP1 alleles.
    Gai K; Okondo MC; Rao SD; Chui AJ; Ball DP; Johnson DC; Bachovchin DA
    Cell Death Dis; 2019 Aug; 10(8):587. PubMed ID: 31383852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the inflammasome and atopic dermatitis susceptibility.
    Bivik C; Verma D; Winge MC; Lieden A; Bradley M; Rosdahl I; Söderkvist P
    J Invest Dermatol; 2013 Oct; 133(10):2486-2489. PubMed ID: 23563199
    [No Abstract]   [Full Text] [Related]  

  • 19. Elucidating the interfaces involved in CARD-CARD interactions mediated by NLRP1 and Caspase-1 using molecular dynamics simulation.
    Maharana J
    J Mol Graph Model; 2018 Mar; 80():7-14. PubMed ID: 29324327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries.
    Mitchell PS; Sandstrom A; Vance RE
    Curr Opin Immunol; 2019 Oct; 60():37-45. PubMed ID: 31121538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.